This document discusses regulatory standards for determining fair market value in medical group-physician financial arrangements. It outlines essential steps for conducting fair market valuations, including deconstructing total compensation into individual components like base salary, bonuses, and payments for additional duties. While market survey data provides benchmarks, the document advises investigating fair market value beyond surveys by considering location, scope of duties, and other relevant facts and circumstances for each arrangement. Medical groups must structure physician compensation prudently according to these standards to avoid regulatory penalties.
Insurance M&A activity in the US rose to unprecedented levels in 2015, surpassing what had been a banner year in 2014. There were 476 announced deals in the insurance sector, 79 of which had disclosed deal values with a total announced value of $53.3 billion. This was a significant increase from the 352 announced deals in 2014, of which 73 had disclosed deal values with a total announced value of $13.5 billion. Furthermore, unlike prior years where US insurance deal activity was isolated to specific subsectors, 2015 saw a significant increase in deal activity in all industry subsectors.
ACA Healthcare legislation and attempts at increasing regulation of self-funding and stop loss coverage are driving more employers toward stop loss captives.
This document provides a summary of recent accounting and tax updates relevant to not-for-profit organizations, including updates from the FASB, GASB, and OMB. It covers new standards and guidance on consolidation, debt issuance costs, retirement benefits, cloud computing arrangements, fair value measurements, and the 2015 OMB Compliance Supplement. The briefing is intended to keep audit committee members informed of changes impacting not-for-profits.
This document provides an overview of Aon plc for investors. It begins with introductory information including leadership and a safe harbor statement. It then discusses Aon's industry-leading position in risk solutions and HR solutions. It highlights the company's global network and presence. The document reviews what Aon has achieved in recent years including focusing its portfolio, investing in capabilities, and delivering strong financial results. Finally, it outlines Aon's plans and targets for the next several years, which include continuing growth, margin expansion, strong free cash flow generation, and long-term value creation for shareholders.
This document discusses Diplomat Pharmacy's financial results and strategies. It summarizes Diplomat's transition to providing broader healthcare services through acquisitions like its PBM acquisition. It also discusses Diplomat's focus on specialty drugs, limited distribution drugs, oncology, and infusion which are driving the pharmacy industry's growth. Finally, it provides an overview of Diplomat's financial performance in recent years which has seen steady revenue and Adjusted EBITDA growth through acquisitions.
Ten Myths of “Say On Pay”
Authors: Professor David F. Larcker, Stanford Graduate School of Business; Allan McCall, co-founder of Compensia and currently a PhD candidate at the Stanford GSB; Gaizka Ormazabal, Assistant Professor of Accounting at IESE Business School at the University of Navarra; and Brian Tayan, Researcher, Corporate Governance Research Program, Stanford GSB.
Published: July 28, 2012
Say on pay is the practice of granting shareholders the right to vote on a company’s executive compensation program at the annual shareholder meeting. Under the Dodd-Frank Act of 2010, publicly traded companies in the U.S. are required to adopt say on pay. Advocates of this approach believe that say on pay will increase the accountability of corporate directors and lead to improved compensation practices.
In recent years, several myths have come to be accepted by the media and governance experts. These myths include the beliefs that:
There is only one approach to “say on pay”
All shareholders want the right to vote on executive compensation
Say on pay reduces executive compensation levels Pay plans are a failure if they do not receive high shareholder support
Say on pay improves “pay for performance”
Plain-vanilla equity awards are not performance-based
Discretionary bonuses should not be allowed
Shareholders should reject nonstandard benefits
Boards should adjust pay plans to satisfy dissatisfied shareholders
Proxy advisory firm recommendations for say on pay are correct
We examine each of these myths in the context of the research evidence and explain why they are incorrect.
We ask:
* Should the U.S. rescind the requirement for mandatory say on pay and return to a voluntary regime?
Read the attached Closer Look and let us know what you think!
To receive monthly alerts about the Closer Look series, please email the Stanford Corporate Governance Research Program at corpgovernance@gsb.stanford.edu. You can also follow more corporate governance
As companies diligently prepare for the 2012 proxy season, they need to be mindful of changes that proxy advisors are making to their voting policies. Institutional Shareholders Services (ISS) recently released its draft policy changes for 2012, which include significant revisions to its methodology for evaluating management say-on-pay (SOP) proposals. Although ISS is accepting comments on its proposed policy changes through November 7th, it is unlikely that there will be any material modifications to them when finalized in November. This article covers the key updates issuers can expect from ISS for 2012.
Insurance M&A activity in the US rose to unprecedented levels in 2015, surpassing what had been a banner year in 2014. There were 476 announced deals in the insurance sector, 79 of which had disclosed deal values with a total announced value of $53.3 billion. This was a significant increase from the 352 announced deals in 2014, of which 73 had disclosed deal values with a total announced value of $13.5 billion. Furthermore, unlike prior years where US insurance deal activity was isolated to specific subsectors, 2015 saw a significant increase in deal activity in all industry subsectors.
ACA Healthcare legislation and attempts at increasing regulation of self-funding and stop loss coverage are driving more employers toward stop loss captives.
This document provides a summary of recent accounting and tax updates relevant to not-for-profit organizations, including updates from the FASB, GASB, and OMB. It covers new standards and guidance on consolidation, debt issuance costs, retirement benefits, cloud computing arrangements, fair value measurements, and the 2015 OMB Compliance Supplement. The briefing is intended to keep audit committee members informed of changes impacting not-for-profits.
This document provides an overview of Aon plc for investors. It begins with introductory information including leadership and a safe harbor statement. It then discusses Aon's industry-leading position in risk solutions and HR solutions. It highlights the company's global network and presence. The document reviews what Aon has achieved in recent years including focusing its portfolio, investing in capabilities, and delivering strong financial results. Finally, it outlines Aon's plans and targets for the next several years, which include continuing growth, margin expansion, strong free cash flow generation, and long-term value creation for shareholders.
This document discusses Diplomat Pharmacy's financial results and strategies. It summarizes Diplomat's transition to providing broader healthcare services through acquisitions like its PBM acquisition. It also discusses Diplomat's focus on specialty drugs, limited distribution drugs, oncology, and infusion which are driving the pharmacy industry's growth. Finally, it provides an overview of Diplomat's financial performance in recent years which has seen steady revenue and Adjusted EBITDA growth through acquisitions.
Ten Myths of “Say On Pay”
Authors: Professor David F. Larcker, Stanford Graduate School of Business; Allan McCall, co-founder of Compensia and currently a PhD candidate at the Stanford GSB; Gaizka Ormazabal, Assistant Professor of Accounting at IESE Business School at the University of Navarra; and Brian Tayan, Researcher, Corporate Governance Research Program, Stanford GSB.
Published: July 28, 2012
Say on pay is the practice of granting shareholders the right to vote on a company’s executive compensation program at the annual shareholder meeting. Under the Dodd-Frank Act of 2010, publicly traded companies in the U.S. are required to adopt say on pay. Advocates of this approach believe that say on pay will increase the accountability of corporate directors and lead to improved compensation practices.
In recent years, several myths have come to be accepted by the media and governance experts. These myths include the beliefs that:
There is only one approach to “say on pay”
All shareholders want the right to vote on executive compensation
Say on pay reduces executive compensation levels Pay plans are a failure if they do not receive high shareholder support
Say on pay improves “pay for performance”
Plain-vanilla equity awards are not performance-based
Discretionary bonuses should not be allowed
Shareholders should reject nonstandard benefits
Boards should adjust pay plans to satisfy dissatisfied shareholders
Proxy advisory firm recommendations for say on pay are correct
We examine each of these myths in the context of the research evidence and explain why they are incorrect.
We ask:
* Should the U.S. rescind the requirement for mandatory say on pay and return to a voluntary regime?
Read the attached Closer Look and let us know what you think!
To receive monthly alerts about the Closer Look series, please email the Stanford Corporate Governance Research Program at corpgovernance@gsb.stanford.edu. You can also follow more corporate governance
As companies diligently prepare for the 2012 proxy season, they need to be mindful of changes that proxy advisors are making to their voting policies. Institutional Shareholders Services (ISS) recently released its draft policy changes for 2012, which include significant revisions to its methodology for evaluating management say-on-pay (SOP) proposals. Although ISS is accepting comments on its proposed policy changes through November 7th, it is unlikely that there will be any material modifications to them when finalized in November. This article covers the key updates issuers can expect from ISS for 2012.
DOL fiduciary rule: How it affects the insurance industry Grant Thornton LLP
We explore how the Department of Labor's final rule expanding the definition of fiduciary investment advice for advisers to retirement plans, participants and beneficiaries will affect the insurance industry.
Physician Practice Acquisitions by Hospitalsjlloyd01
The document summarizes key issues related to physician practice acquisitions by hospitals, known as "buy and employ" transactions. It discusses typical transaction structures, key valuation issues such as determining fair market value and commercial reasonableness, regulatory compliance considerations, and accounting for the transactions. The presentation provides an overview of valuation methods and financial analysis used to value physician practices and assess transaction terms.
The document provides an overview of Diplomat Pharmacy Inc., a specialty pharmacy company. It summarizes that Diplomat is continuing its transition to become a broader healthcare company by acquiring a pharmacy benefit manager (PBM) to expand its services. It also notes that specialty drug growth is far outpacing traditional drugs, and Diplomat has extensive access to limited-distribution drugs which provides a competitive advantage. Adjusted EBITDA and EPS metrics are presented to evaluate operating performance on a non-GAAP basis.
This document contains an agenda and overview for an Aon plc presentation from October 2014. It discusses Aon's industry-leading positions in risk solutions and HR solutions, its largest global network of resources and capabilities, and the growing markets it operates in around the world. It notes that over the last several years, Aon has focused its portfolio, significantly invested in global capabilities, and delivered on key financial metrics. The presentation will provide further details on Aon's achievements and plans for the next several years.
This document investigates how profitability of cement companies in Pakistan is influenced by selected financial and economic indicators. It analyzes data from 12 cement companies over 2005-2008. The study finds that only GDP growth has a significant positive impact on profitability. Financial leverage seems to negatively impact profitability, contrary to some theories. Liquidity and sales growth show weak positive relationships with profitability. Average share price also shows a weak positive linkage. The results indicate inconsistencies in company cost structures and that share prices may not fully reflect financial performance. The conclusions could help cement companies better manage profitability.
The IRS issued Notice 2015-16 seeking comments on key issues related to the upcoming "Cadillac tax" on high-cost employer health plans. The notice focuses on defining "applicable coverage", determining the cost of coverage, and applying the annual dollar limits. The IRS specifically requests input on topics like the treatment of health reimbursement arrangements, on-site medical clinics, and how dollar limits should apply when employees have multiple types of coverage. Comments are requested by May 15 to help guide future rulemaking around calculating and assessing the 40% excise tax.
Longwood Capital Advisors seeks funding from private investors to invest in public biotech and pharmaceutical companies. It focuses on small-cap companies with drugs in late-stage clinical trials or pending FDA approval. By leveraging the partners' medical and scientific expertise, LCA analyzes clinical data and FDA processes to evaluate investment opportunities. Since 2012, LCA has generated an average annual return of 28.8% while mitigating risk through position size limits and automatic stop losses.
This document contains an agenda and presentation for Aon plc to discuss their industry-leading franchise focused on risk and people solutions, what they have achieved over the last several years, and what they will do over the next several years. It discusses that Aon is #1 in risk solutions and #1 in HR solutions, has the largest globally owned network of resources and capabilities, and operates in growing markets. It notes that over the last several years Aon focused its portfolio, significantly invested in global capabilities, and delivered on key financial metrics. It aims to outline what Aon will do to continue building on this in the coming years.
DOL Webcast - DOL Fiduciary Rule Impacts Implications_12-04-16Johan Joseph, CFA
The document discusses the new Department of Labor fiduciary rule which expands the definition of fiduciary investment advice and precludes advisors from receiving payments that create conflicts of interest. It provides an overview of the rule, its timeline and key aspects including applicability, exemptions, and the requirement for advisors to act in their clients' best interest by avoiding conflicts of interest and providing fee disclosures. It also discusses the potential impacts on different types of organizations and how organizations are responding by rationalizing products, seeking partnerships, updating technology, changing compensation structures, and flexing operating models.
This document analyzes the compensation of former Valeant Pharmaceuticals CEO J. Michael Pearson. Pearson received a large compensation package heavily tied to stock performance targets. Under Pearson, Valeant grew rapidly through acquisitions but also took on significant debt. While the stock initially soared, scrutiny of Valeant's business practices intensified and the stock price collapsed in 2015-2016. Pearson was replaced as CEO, though his successor also received a largely performance-based compensation package. The document discusses debates around how executive pay incentives can encourage risk-taking and whether Valeant's approach was sustainable.
Key Growth Sectors in the Health Care Services M&A MarketRobert James Cimasi
The document discusses a webcast on key growth sectors in the health care M&A market. It provides an agenda that will discuss trends in hospital, physician groups, managed care, and financing. It then introduces several speakers who will provide perspectives on health care services M&A trends.
20151022 PPI Comparison of DC pensions regulatorsSarah Luheshi
This document summarizes a report that compares the regulatory frameworks for defined contribution pensions in the UK that are trust-based, regulated by The Pensions Regulator (TPR), and contract-based, regulated by the Financial Conduct Authority (FCA). It finds that while both regulators aim to protect consumers, the FCA regime is more rigorous in preventing issues, while the TPR regime focuses on enabling trustees and addressing issues after the fact. Both regimes have strengths that could help the other improve. Ensuring adequate contributions from employers is an important role of TPR. Concerns include potential winding up of some master trusts and lack of transparency potentially leading to worse outcomes.
Diplomat investor presentation january 2018DiplomatIR
Diplomat Pharmacy Inc. is transitioning to a broader healthcare company by acquiring PBMs that expand its services. It acquired NPS and LDI, two full-service PBMs, to address unmet market needs across specialty pharmacy. Specialty drugs are growing much faster than traditional drugs, and Diplomat has extensive access to limited distribution drugs. The acquisitions provide a robust PBM platform and complementary products, services, and solutions to accelerate growth.
Final dplo q1 2018 operating results ir deckDiplomatIR
This document summarizes Diplomat Pharmacy's growth strategy and financial outlook. It discusses how specialty drugs are an increasing portion of healthcare spending and how Diplomat is positioned as the largest independent specialty pharmacy. The summary also mentions Diplomat's expansion into PBM services, specialty infusion, and focus on managing costs and patient care. Financially, Diplomat expects continued revenue growth and for adjusted EBITDA to reach $164-170 million in 2018.
The document provides an overview of Aon plc, a global professional services firm focused on risk, retirement, and health solutions. It summarizes Aon's industry-leading position, global network of over 500 offices in 120 countries, and operations in growing insurance and HR consulting markets. The document also outlines steps Aon has taken to focus its portfolio, invest in capabilities, and deliver strong financial results including 3-4% annual organic revenue growth, 19-22% operating margins, and over $1 billion in annual free cash flow. Finally, it discusses opportunities for further value creation such as united growth efforts, continued margin expansion, effective capital allocation, and long-term shareholder returns.
Dplo q1 2018 operating results ir deck (1)DiplomatIR
This document summarizes Diplomat Pharmacy's growth strategy and financial outlook. It discusses how specialty drugs are an increasing portion of healthcare spending and how Diplomat is positioned as the largest independent specialty pharmacy. The summary also notes Diplomat's expansion into PBM services, specialty infusion, and focus on managing costs and delivering personalized care to patients. Financially, Diplomat expects continued revenue growth between $5.5-5.9 billion in 2018 and adjusted EBITDA between $164-170 million, reflecting investments to capitalize on specialty drug market opportunities.
The document discusses trends in the specialty pharmacy industry and Diplomat Pharmacy's position to capitalize on these trends. It notes that specialty drugs are expected to grow from 25% to 50% of pharmacy industry revenues from 2011 to 2021. It also outlines how Diplomat has decades of experience in high-growth specialty categories, a growing portfolio of limited-distribution drugs, and is creating efficiencies to address increasing healthcare costs. The document positions Diplomat to benefit from industry trends through its multiple service lines and recent acquisitions.
Controlling Workers’ Compensation Costs by as Much as 20% - 50%Richard Swartzbaugh
What is Workers’ Compensation?
Who Benefits from Workers’ Compensation Cost Control? Everyone!!!
Worker’s Comp costs can be one of your Company’s greatest “out of control” costs, or, YOU can but in a proven 19-step system to reduce Workers’ Comp costs by as much as 20% - 50%, and utilize critical metrics to address:
- Why workers’ compensation metrics are important
- The formulas for how to calculate 5 critical metrics
- How to leverage these metrics to make an impact at your organization
Following the step-by-step instructions in 19-Step system for the calculation and application of critical metrics will address:
- Workers’ comp viewed as a cost of doing business
- Getting management to understand value of return to work
- Convincing policy holders to embrace a worker recovery program
- Lack of informed and effective employer involvement in WC claims issues
- Stakeholder apathy
- Managers and supervisors not taking seriously their duty to protect workers
Avoiding Workers’ Comp mistakes & loopholes will help drive three major points:
- Drivers of human behavior
- Disincentives to “Return to Work”
- Most common employer mistakes
Finally:
- Evidence-based medicine will create better Workers’ Comp claim outcomes.
- In organized environments, executing successful return to work programs with Unions (and members) is essential.
- As part of a comprehensive workers compensation program, employers should maintain close communications with injured employees to ensure they recover quickly, do not drop out of the workforce and return to work rapidly. Get Well Cards are part of a positive, proactive communication strategy.
PYA Principal Carol Carden and Senior Manager Angie Caldwell presented “Hot Topics in Physician Compensation” at the Kentucky Society of CPAs (KY CPA) Health Care Conference, May 18, 2016. The presentation explored the latest developments in physician compensation structure, as well as considerations related to stacking compensation elements, the role and impact of quality incentives, the latest in affiliation models, and population health initiatives.
DOL fiduciary rule: How it affects the insurance industry Grant Thornton LLP
We explore how the Department of Labor's final rule expanding the definition of fiduciary investment advice for advisers to retirement plans, participants and beneficiaries will affect the insurance industry.
Physician Practice Acquisitions by Hospitalsjlloyd01
The document summarizes key issues related to physician practice acquisitions by hospitals, known as "buy and employ" transactions. It discusses typical transaction structures, key valuation issues such as determining fair market value and commercial reasonableness, regulatory compliance considerations, and accounting for the transactions. The presentation provides an overview of valuation methods and financial analysis used to value physician practices and assess transaction terms.
The document provides an overview of Diplomat Pharmacy Inc., a specialty pharmacy company. It summarizes that Diplomat is continuing its transition to become a broader healthcare company by acquiring a pharmacy benefit manager (PBM) to expand its services. It also notes that specialty drug growth is far outpacing traditional drugs, and Diplomat has extensive access to limited-distribution drugs which provides a competitive advantage. Adjusted EBITDA and EPS metrics are presented to evaluate operating performance on a non-GAAP basis.
This document contains an agenda and overview for an Aon plc presentation from October 2014. It discusses Aon's industry-leading positions in risk solutions and HR solutions, its largest global network of resources and capabilities, and the growing markets it operates in around the world. It notes that over the last several years, Aon has focused its portfolio, significantly invested in global capabilities, and delivered on key financial metrics. The presentation will provide further details on Aon's achievements and plans for the next several years.
This document investigates how profitability of cement companies in Pakistan is influenced by selected financial and economic indicators. It analyzes data from 12 cement companies over 2005-2008. The study finds that only GDP growth has a significant positive impact on profitability. Financial leverage seems to negatively impact profitability, contrary to some theories. Liquidity and sales growth show weak positive relationships with profitability. Average share price also shows a weak positive linkage. The results indicate inconsistencies in company cost structures and that share prices may not fully reflect financial performance. The conclusions could help cement companies better manage profitability.
The IRS issued Notice 2015-16 seeking comments on key issues related to the upcoming "Cadillac tax" on high-cost employer health plans. The notice focuses on defining "applicable coverage", determining the cost of coverage, and applying the annual dollar limits. The IRS specifically requests input on topics like the treatment of health reimbursement arrangements, on-site medical clinics, and how dollar limits should apply when employees have multiple types of coverage. Comments are requested by May 15 to help guide future rulemaking around calculating and assessing the 40% excise tax.
Longwood Capital Advisors seeks funding from private investors to invest in public biotech and pharmaceutical companies. It focuses on small-cap companies with drugs in late-stage clinical trials or pending FDA approval. By leveraging the partners' medical and scientific expertise, LCA analyzes clinical data and FDA processes to evaluate investment opportunities. Since 2012, LCA has generated an average annual return of 28.8% while mitigating risk through position size limits and automatic stop losses.
This document contains an agenda and presentation for Aon plc to discuss their industry-leading franchise focused on risk and people solutions, what they have achieved over the last several years, and what they will do over the next several years. It discusses that Aon is #1 in risk solutions and #1 in HR solutions, has the largest globally owned network of resources and capabilities, and operates in growing markets. It notes that over the last several years Aon focused its portfolio, significantly invested in global capabilities, and delivered on key financial metrics. It aims to outline what Aon will do to continue building on this in the coming years.
DOL Webcast - DOL Fiduciary Rule Impacts Implications_12-04-16Johan Joseph, CFA
The document discusses the new Department of Labor fiduciary rule which expands the definition of fiduciary investment advice and precludes advisors from receiving payments that create conflicts of interest. It provides an overview of the rule, its timeline and key aspects including applicability, exemptions, and the requirement for advisors to act in their clients' best interest by avoiding conflicts of interest and providing fee disclosures. It also discusses the potential impacts on different types of organizations and how organizations are responding by rationalizing products, seeking partnerships, updating technology, changing compensation structures, and flexing operating models.
This document analyzes the compensation of former Valeant Pharmaceuticals CEO J. Michael Pearson. Pearson received a large compensation package heavily tied to stock performance targets. Under Pearson, Valeant grew rapidly through acquisitions but also took on significant debt. While the stock initially soared, scrutiny of Valeant's business practices intensified and the stock price collapsed in 2015-2016. Pearson was replaced as CEO, though his successor also received a largely performance-based compensation package. The document discusses debates around how executive pay incentives can encourage risk-taking and whether Valeant's approach was sustainable.
Key Growth Sectors in the Health Care Services M&A MarketRobert James Cimasi
The document discusses a webcast on key growth sectors in the health care M&A market. It provides an agenda that will discuss trends in hospital, physician groups, managed care, and financing. It then introduces several speakers who will provide perspectives on health care services M&A trends.
20151022 PPI Comparison of DC pensions regulatorsSarah Luheshi
This document summarizes a report that compares the regulatory frameworks for defined contribution pensions in the UK that are trust-based, regulated by The Pensions Regulator (TPR), and contract-based, regulated by the Financial Conduct Authority (FCA). It finds that while both regulators aim to protect consumers, the FCA regime is more rigorous in preventing issues, while the TPR regime focuses on enabling trustees and addressing issues after the fact. Both regimes have strengths that could help the other improve. Ensuring adequate contributions from employers is an important role of TPR. Concerns include potential winding up of some master trusts and lack of transparency potentially leading to worse outcomes.
Diplomat investor presentation january 2018DiplomatIR
Diplomat Pharmacy Inc. is transitioning to a broader healthcare company by acquiring PBMs that expand its services. It acquired NPS and LDI, two full-service PBMs, to address unmet market needs across specialty pharmacy. Specialty drugs are growing much faster than traditional drugs, and Diplomat has extensive access to limited distribution drugs. The acquisitions provide a robust PBM platform and complementary products, services, and solutions to accelerate growth.
Final dplo q1 2018 operating results ir deckDiplomatIR
This document summarizes Diplomat Pharmacy's growth strategy and financial outlook. It discusses how specialty drugs are an increasing portion of healthcare spending and how Diplomat is positioned as the largest independent specialty pharmacy. The summary also mentions Diplomat's expansion into PBM services, specialty infusion, and focus on managing costs and patient care. Financially, Diplomat expects continued revenue growth and for adjusted EBITDA to reach $164-170 million in 2018.
The document provides an overview of Aon plc, a global professional services firm focused on risk, retirement, and health solutions. It summarizes Aon's industry-leading position, global network of over 500 offices in 120 countries, and operations in growing insurance and HR consulting markets. The document also outlines steps Aon has taken to focus its portfolio, invest in capabilities, and deliver strong financial results including 3-4% annual organic revenue growth, 19-22% operating margins, and over $1 billion in annual free cash flow. Finally, it discusses opportunities for further value creation such as united growth efforts, continued margin expansion, effective capital allocation, and long-term shareholder returns.
Dplo q1 2018 operating results ir deck (1)DiplomatIR
This document summarizes Diplomat Pharmacy's growth strategy and financial outlook. It discusses how specialty drugs are an increasing portion of healthcare spending and how Diplomat is positioned as the largest independent specialty pharmacy. The summary also notes Diplomat's expansion into PBM services, specialty infusion, and focus on managing costs and delivering personalized care to patients. Financially, Diplomat expects continued revenue growth between $5.5-5.9 billion in 2018 and adjusted EBITDA between $164-170 million, reflecting investments to capitalize on specialty drug market opportunities.
The document discusses trends in the specialty pharmacy industry and Diplomat Pharmacy's position to capitalize on these trends. It notes that specialty drugs are expected to grow from 25% to 50% of pharmacy industry revenues from 2011 to 2021. It also outlines how Diplomat has decades of experience in high-growth specialty categories, a growing portfolio of limited-distribution drugs, and is creating efficiencies to address increasing healthcare costs. The document positions Diplomat to benefit from industry trends through its multiple service lines and recent acquisitions.
Controlling Workers’ Compensation Costs by as Much as 20% - 50%Richard Swartzbaugh
What is Workers’ Compensation?
Who Benefits from Workers’ Compensation Cost Control? Everyone!!!
Worker’s Comp costs can be one of your Company’s greatest “out of control” costs, or, YOU can but in a proven 19-step system to reduce Workers’ Comp costs by as much as 20% - 50%, and utilize critical metrics to address:
- Why workers’ compensation metrics are important
- The formulas for how to calculate 5 critical metrics
- How to leverage these metrics to make an impact at your organization
Following the step-by-step instructions in 19-Step system for the calculation and application of critical metrics will address:
- Workers’ comp viewed as a cost of doing business
- Getting management to understand value of return to work
- Convincing policy holders to embrace a worker recovery program
- Lack of informed and effective employer involvement in WC claims issues
- Stakeholder apathy
- Managers and supervisors not taking seriously their duty to protect workers
Avoiding Workers’ Comp mistakes & loopholes will help drive three major points:
- Drivers of human behavior
- Disincentives to “Return to Work”
- Most common employer mistakes
Finally:
- Evidence-based medicine will create better Workers’ Comp claim outcomes.
- In organized environments, executing successful return to work programs with Unions (and members) is essential.
- As part of a comprehensive workers compensation program, employers should maintain close communications with injured employees to ensure they recover quickly, do not drop out of the workforce and return to work rapidly. Get Well Cards are part of a positive, proactive communication strategy.
PYA Principal Carol Carden and Senior Manager Angie Caldwell presented “Hot Topics in Physician Compensation” at the Kentucky Society of CPAs (KY CPA) Health Care Conference, May 18, 2016. The presentation explored the latest developments in physician compensation structure, as well as considerations related to stacking compensation elements, the role and impact of quality incentives, the latest in affiliation models, and population health initiatives.
Clinical Co-Management Arrangements: Trends, Issues and FMV ConsiderationsCBIZ, Inc.
Healthcare providers are under scrutiny and feel pressure from patients, employers, insurance and the federal and state governments to provide higher quality care at lower costs and higher efficiency.
Privately owned physician practices have specialized in certain medical areas like heart disease, orthopedics, and spinal care. Over 30 years, their actions have led to operating outside the scope of quality patient care. Doctors were unhappy with low reimbursement rates from Medicare/Medicaid and felt entitled to higher fees. They sought to partner with private investors and operate as healthcare delivery businesses instead of under the hospital payment system to get around regulations. This resulted in the creation of sole proprietorships in medicine and led to the development of Stark Laws prohibiting physician self-referrals.
This document provides an overview of the valuation of Superior Integrated Home Health Care Ltd., a home health agency that participates in the Medicare program. It discusses key characteristics of Medicare provider businesses that distinguish them from typical private businesses and impact their valuation. These include heavy regulation and compliance requirements, lack of contractual payment rights subjecting revenue to suspension or recoupment, lack of market forces determining prices, and risk of personal liability for owners.
Online Conference Takes “Deep Dive” into Affordable Care ActPYA, P.C.
PYA’s Martie Ross, Principal, joined three other panelists in a full-day, online conference sponsored by the American Institute of Certified Public Accountants to offer an in-depth look at healthcare reform under the Affordable Care Act (ACA).
Provider/payor convergence: A prescription for growth?Grant Thornton LLP
As bottom lines shrink, payors and providers are beginning to see convergence, or vertical integration, as the path to growth, Panelists from Johns Hopkins Institutions, Buchanan Ingersoll & Rooney PC and Grant Thornton LLP share their experience.
Key Trends in ASC Valuations: Benchmark and use common valuation methodologiesCBIZ, Inc.
This document discusses key topics related to ASC valuations:
- Benchmarking an ASC's performance against industry metrics is important to understand areas that are strong or need improvement and how this impacts valuation.
- The three main valuation methodologies used are income, market, and cost approaches, with income and market most relevant for ASCs.
- Common errors in ASC valuations include failing to understand regulations, reimbursement, local market conditions, or making unsupported assumptions about growth, capacity, or normalizing financials. Having a knowledgeable valuation professional is important to avoid errors.
Hot Valuation Issues for Physician AgreementsPYA, P.C.
The document summarizes key issues related to physician compensation agreements and the impact of healthcare reform. It discusses the increased complexity of compensation models with multiple layers and components. Ensuring fair market value and commercial reasonableness of the overall arrangement is important as the sum of individual components could exceed what is reasonable. The presentation also covers analyzing losses, benchmarks, and factors considered in commercial reasonableness determinations. Healthcare continues shifting toward value-based payments, quality incentives, and bundled payments through initiatives like Accountable Care Organizations.
Physican compensation presentation for physicians 270513Patricia Burchall
The document provides an overview of a project to develop a new physician compensation framework for Bermuda Hospitals Board (BHB). It finds that BHB's current compensation levels do not consistently align with comparator markets and lack clear governance, productivity expectations, and definitions of full-time work. Additionally, performance-based bonuses sometimes result in total compensation exceeding market benchmarks. The document recommends reviewing bonus formulas and physician productivity expectations to improve alignment with the current environment.
This document outlines a sample claims management process for a physician practice with 14 steps. The process begins with patient registration, verification of insurance benefits, and check-in. It continues with clinical documentation of services, assigning codes, patient check-out, coding review, pre-authorization if needed, claim generation, claim review, processing by the health insurer, collections if needed, posting payments, appeals if claims are denied, and ends with a glossary. Implementing this detailed process is intended to increase efficiency, submit clean claims, reduce denials, and ensure timely payments from health insurers.
The audit plan summarizes the key elements of the revenue recognition guidance and provides an overview of the audit risk assessment for New York Presbyterian Hospital for the year ended December 31, 2014. Specifically, it outlines the general revenue recognition standards, industry-specific standards for hospitals and medical practices, describes the material revenue streams and patient mix for NYP, and assesses the inherent risk of NYP's revenue recognition process as relatively low. A preliminary analytical review found that NYP's revenue increased by $109 million from 2013 to 2014, which is likely due to its acquisition of Lawrence Hospital Center in July 2014.
Mastering Pharmacy Medical Billing + Claims Submissionkendall100
Claim your free access to invaluable pharmacy billing guides and streamline your processes with confidence. Pharmacy billing encompasses submitting claims to insurance payers for reimbursement for pharmacy services. These services range from dispensing medications to providing medication therapy management (MTM) and other clinical interventions you can bill for!
Massachusetts has enacted some of the strictest healthcare laws in the US. The regulations require companies to adopt a marketing code of conduct based on the AdvaMed code, implement compliance programs, and disclose payments to Massachusetts healthcare providers annually. Companies must limit interactions with providers that could influence prescribing and increase payment transparency. Non-compliance can result in fines up to $5,000 per violation.
The document discusses the potential impact of 2010 health care reform on WellPoint, Inc., a major health insurance carrier. It outlines key provisions of the reform legislation, analyzes how different parts of WellPoint's business may be affected in terms of membership mix, costs and revenues. The document also reviews WellPoint's financial and enrollment data and considers options for marketing and distribution strategies in light of the regulatory changes.
In Module One, our first step is to direct our focus on what healtrafbolet0
In Module One, our first step is to direct our focus on what healthcare reimbursement means and how that meaning will be applied throughout the course. In Module One, you will be provided with explanations of the terminology and methodologies surrounding the cost of healthcare services and, subsequently, how providers of those services are compensated.
Reimbursement in a healthcare context refers to the payment that providers and facilities receive for the services that they provide their patients. Providers and facilities include physicians, hospitals, clinics, outpatient rehabilitation centers, home healthcare centers, and other healthcare facilities. Many providers are not-for-profit as opposed to investor-owned.
Questions that will be answered in this module include:
· What are reimbursement methodologies and how do they impact healthcare organizations?
· What are the current trends in healthcare reimbursement?
· How might healthcare administrators differentiate between reimbursement methods?
· How are financial management principles applied to reimbursement methods?
· Who are the key stakeholders surrounding healthcare reimbursement?
The answers to these questions will provide you with a better understanding of the background, context, and trends surrounding healthcare reimbursement systems. Further, you will find it helpful to assume the role of a healthcare administrator as you practice what it would be like to assume a management position. Although you will have your own personal opinions based on experiences from a patient perspective, for this course, you will view the assignments through the lens of the healthcare administrator. The administrator is challenged with providing the best care and services to the communities that they serve, while charging a price that is affordable to both the patient and the organization. The administrator must also take into account the various compliance standards and government regulations.
Why Study Reimbursement?
Healthcare administrators and other health personnel can better meet the needs of their patients, clients, and organization by offering clear guidelines and cost structures concerning healthcare reimbursement. The key stakeholders of healthcare reimbursement systems are patients, healthcare providers, and third-party processors. As such, there are many perspectives to consider when administrators develop strategic plans designed around revenue generation. Many healthcare administrators are involved in contract management decisions and also represent their organizations by negotiating with managed care organizations and third-party payers.
The Affordable Care Act is one of the largest pieces of healthcare legislation in our era. The law itself is over 1,000 pages covering funding, Health Insurance Portability and Accountability Act (HIPAA) requirements, insurance coverage, health information systems, and reimbursement. Not surprisingly, this has contributed to the increase in employm ...
Hospital Workers’ Compensation Claims: Strategies for Successitduediligence
Workers’ compensation claims typically account for only 3-5% of a hospital’s revenue, but require an inordinate amount of effort to bill and collect in a compliant manner. On the surface, workers’ compensation claims may appear to be similar to claims from any other payer. The patient is registered, insurance coverage is identified, the patient is treated, and bills are submitted. Any denials are addressed and ultimately cash is posted after confirming proper reimbursement. Hospitals have processes in place to deal with these functions every day. As demonstrated in this white paper, however, each step in the revenue cycle related to a workers’ compensation claim involves unique challenges.
The document is a report from the Insurance Regulatory and Development Authority's Committee to Evaluate the Performance of Third Party Administrators (Health Services) from April 2009.
The report provides recommendations on the scope of activities TPAs can engage in, best practices for customer service, and infrastructure and financial requirements for TPAs. It recommends standardizing processes, documents, timelines and establishing a common industry body. It also suggests increasing capital requirements for TPAs based on revenue amounts to ensure adequate infrastructure and financial security. The creation of an industry association for TPAs is endorsed to help standardize the sector and address issues collectively.
Similar to Analyzing compensation-at-fair-market-value (20)
1. Medical Group Strategy Council
Analyzing Compensation at
Fair Market Value
Translating Regulatory Standards for Medical Group-Physician
Financial Arrangements
Tomi Ogundimu
Consultant
202-568-7382
OgundimT@advisory.com
Randy Gott
Senior Vice President, Southwind
615-794-5169
GottR@advisory.comGott
2445 M Street NW | Washington DC 20037 | P 202.266.5600 | F 202.266.5700 | advisory.com